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Now and Then Above: 2001 graduates Shannon McElearney, MD, Joanna
Oda, MD, and Lineo Thahane, MD, from lefl. The School of Medicine conferred 122
degrees on May 18: 102 students received the MD degree, 14 received the MD/PhD
degree, and six received the MDI MA degree. 8elow: Reunion 2001 brought together
1986 classmates Maggie McCracken, MD, Alison Whelan, MD, associate dean for
medical student education, and Michelle 8utzer Ruby, MD, from left.
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assortment of pills, which in various combinations make
up the "cocktail," the therapy which has proven to be
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a lifeline for many people infected with HIV (green
model). He and his colleagues at the School of Medicine's
AIDS Clinical Trials Unit (ACTU) help patients manage

I Can See Clearly Now

the disease, while holding out hope for better treatments.

An exci ting new therapy aJlows some older adults with

The potent drug mixture allows people to live longer and

age-related eye disease to regain vision and independence.

BY CANDACE O'CONNOR

healthier lives, yet its long-term consequences are just
beginning to be understood. Examining the cocktail's
powerful effect on the body is becoming a fo cus of AIDS
research. For more on this story, please turn to page 12.

The Cocktail Conundrum

BY GILA Z. RECKESS

The much-lauded drug "cocktail" enables persons with
A1DS to live longer, healthier lives-but at what cost?

The Immune System vs. Tumors

BY GILA Z. RECKESS

Linking immunology and oncolo gy, researchers find
the immune system plays a role in tumor formation.

Smile Doctor

BY DAVID LINZEE

Providing pediatric dentistry for specia l-needs kids
is a prioriry and a pleasure for one faculry member.
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JEFFREY

r. GO RDON, MD , the Alumni Professo r

and h ead of molecular biology and pharmacology,
was one of 72 new m embers elected to the Nation al
Academ y of Sciences on May 1, 200 1. Election to th e
academy is considered one of the hig hes t honors tha t
ca n be bestowed on an
American scien tist or
engineer, and its members
are chosen in recognition
of their distinguished and
con tinuing achievements
in original research.
Gordon is known for his
resea rch o n gastro intestinal
development and how gut
Jeffrey I. Gordon, !VI D
bac teria affec t normal intes
tinal function and pred ilection to certain diseases. His
research may help scientists understand such commo n
human diseases as in flammatory bowel di sease, irritabl e
bowel syndrome and stomach ulcers.
In addition, Go rd on's lab has studied an enzyme,
N-myristoyltransferase, tha t affec ts the fun ct ions of
m a ny cellular proteins a nd is requ ired for the survival
of fun gi that cause syste mic infections in humans with
compromised immun e sys tems.
Gordon also is director of the Divi sio n of Biology
and Biomedica l Sciences, wh ich oversees all PhD and
MD/PhD students in th e biological sciences, and has
mentored more than 60 young researc hers.

Boxerman assumes leadership of HAP
STUART B. BOXERMAN, DSC, has been named

director of the Health Administration Program at the
School of Medicine. He had been serving as interim
director of the program since July 2000, followi ng th e
re tirement of James O. Hepner, PhD .
Boxe rman ea rned three degrees from Washington
Unive rsiry. Two were in engineering-a bachelor's degree
in 1963 and a maste r's degree in 1965. In 1970, he was
awa rded hi s doctorate in applied mathematics and
computer sCience.
The Health Ad mini strati on Program, founded in

1946, provides its students with a firm foundation in
management integrated with a solid understandin g of
the health care field and its current delivery systems.
Summer 2001
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Gelberman named AAOS president
RICHARD H. GELBERMAN, MD, the Fred C. Reynolds

Professor and head of orthopaedic surgery, recently became
presid enc of the 25,5 00-member American Academy of
Orchopaedic SurgelY (AAOS) at its 68th annual meeting
and scientific sess ions in San Francisco CA.
A mem ber of the academy since 1981, Gelberman
h as served on more than a dozen of its committees and
task fo rces. Most recently, he had been one of the organi
za ti o n's vice presidents. As president, he plans to initi ate
a new program designed to improve musculoskeletal care
for the public through better education for doctors.
Gelberman also is chief of hand and wrist surgery
and directo r of the hand and upper extremity fellowship
traini ng program at the School of Medicine, and is
orthopaedic-surgeon-in-chief at Barnes-Jewish and
St. Louis Children's hospitals.

H e has had support from
th e N ation al In stitutes of
H ea lth for hi s research on
dense regular connective tis
sue sin ce 1976. He also has
research interests in radius
fract ures, ca rpal instabili ty
and nerve injuries.
Gelberman is the author
of more than 200 scientific
Richard H. Gelberman, MD
............................................. ....... man uscripts and has recei ved
m any awards for his research. He has served on the edito
rial boards o f several medi cal publications, and currently
serves as a reviewer for the Journal of Bone and Joint
Surger)1 and the Journal ofOrthopaedic Research.
The AAOS is a no t-for-profit organization that
provides education programs for orthopaedic surgeons,
alli ed health professionals and the public.

NEUROLOGY

Mild cognitive impairment appears to be Alzheimer'S disease
OST PEOPLE DIAGNOSED with mild
cognitive impairment (Mel) evenrualJy
develop Alzheimer's disease, researchers with
the School of Medicine's Memory and Aging
Project (MAP) have found. The results suggest that Mel,
characterized by minor memory loss, is an early stage of
Alzheimer's rather than a separate disorder.
"We were surprised to find that an
unexplained memory deficit that is cur
rendy called MCl almost always turns
out to be early Alzheimer's," says John
C. Morris, MD, Harvey A. and
D orismae H acker Friedman Professor
of Neurology, director of MAP and
co-director of the Alzheimer's Disease
Research Center. He is first author of a
paper on the subject that appeared in
the March issue of Archives ofNeurology.
Researchers examined 404 peopl e
who had either mild memory loss or no memory prob
lems and who volunteered for annual mem ory assess
ments at MAP betwee n July 1990 and June 1997. The
227 individuals with MCI were placed into one of three
categories: fairly confident, suspicious and uncertain. The
categories reAected the researchers' degree of confidence
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that the subtle signs of memory loss might indicate the
onset of Alzh eimer's disease.
The volunteers were reassessed annually for up to
9.5 years. After five years, Alzheimer symptoms had
developed in 6.8 percent of the healthy volunteers,
19.9 percent of the individuals in the uncertain MCl
group, 35.7 percent of those in the suspicious group and
60.5 percent of those in the fairly
confident group. By 9.5 years. all of
the volunteers with the most severe
form ofrvlCl had developed the
clinical symptoms of Alzheimer's.
Forry-two participants died before
the end of the srudy and donated
their brains for postmortem analysis,
the only way to diagnose Alzheimer's
disease with complete accuracy.
Autopsies of 25 volunteers who origi
nally were diagnosed with MCI
confirmed that 21 had Alzheimer's disease.
M orris points out that these results are based on a
select group of individuals who volunteered for memory
research. "Even with that caveat, the findings are impres
sive," he says. Earlier diagnosis will help scientists develop
more etTective therapies for early intervention.
Pulse 3

Teitelbaum is FASER president-elect

The mission of FASEB
is ro en hance che abili ry of

STEVEN L. TEITELBAUM, MD, has been selected as

biomedical and life sciemiscs

the nexc presidenr-elect of the Fed eration of American
Sociecies for Experimencal Biology (FASEB), effeccive

ro improve, through cheir
research, the healch, well

July 1, 2001. FASEB is che largest coaJicion of biomedical

being and productivity of

research associations in che United States, represeming

all people. The organization
serves the imerests of these

21 sociecies wich more chan 60,000 members.
Teicelbaum , who is che Wilma and Roswell Messing
Professor of Pathology, will serve as che group's president
in 2002-2003. Also a pathologist ac Barnes-Jewish
Hospital and Sc. Louis Shriners HospitaJ, Teitelbaum

sciemists, particularly in

Steven l. Teitelbaum, MD

areas related to publ ic policy.
The group also facilitaces coalicion activi ties among
m ember societies and di ssemina ces information on

sets a primary goal in his new role to promoce federal

biological research through scientific conferences and

funding of biomedical and life sciences research.

publications.

PHARMACOGENETICS

Drug resistance found to vary by ethnicity

A

enetic mutation affecting resistance
to chemotherapy occurs more fre
quently in some ethnic groups than
in others, according to a new study.
Researchers found that African and
African-American populations included
more individuals with the drug-resistant
gene than Caucasian or Asian popula
tions. This might help explain why
some people of African descent
respond poorly to chemotherapy.
The research was presented March
25, 2000, at the annual meeting of
the American Association for
Cancer Research in New Orleans.
"We now know that the genetic
influence on drug resistance is not
the same throughout the whole popula
tion," says Howard L. McLeod, PharmO,
associate professor of medicine, of phar
macology and molecular biology and of
genetics. "Because of this work, we can
try to solve the problem:'
McLeod, who led the international
team of researchers from his previous
position at the University of Aberdeen in
the United Kingdom, specializes in phar
macogenetics, an emerging research field.
4 Pulse

Margaret-Mary Ameyaw, MO, PhD, of the
University of Aberdeen, is the study's first
author and will join the Washington
University faculty later this year.

The mutation studied by McLeod
and his colleagues changes production of
a protein called P-glycoprotein, or PGP, a
molecular pump that rids cells of drugs.
When working correctly, PGP pumps
chemotherapeutic drugs out of tumors,
allowing the tumor cells to survive. This

response is known as drug resistance.
The genetic mutation means the PGP
pump stops working, allowing drugs to
enter and kill tumor cells.
Working with collaborators in five
countries, McLeod and his colleagues did
DNA tests on blood samples from 1,280
people from 10 ethnic populations. They
found that some populations were sig
nificantly more likely than others to
contain the mutation. The groups of
African descent-Ghanaian, Kenyan,
African American and Sudanese
had the mutation significantly less
frequently than Caucasian and Asian
populations tested.
Because lack of the mutation
is associated with higher expression
of PGP and thus higher drug resistance,
these findings mean that physicians may
soon have the necessary tools for individu
alizing therapy, especially for people of
African heritage. Extreme interventions,
such as gene therapy, would not be
necessary because an existing medication
that chemically inhibits the PGP protein
could be given to people found to
overexpress PG P.
Summer 200 I Outlook

Students, faculty receive Academic Women's Network 2001 awards
THREE STUDENTS AND TWO PROFESSORS

recently were recognized for their achievements by the
university's Academic Women's Network (AWN).
Each year, the AWN recognizes graduating students
in either the MD or PhD programs at the medical
school based upon their demonstrated outstanding lead
ership in service ro or advancement of wome n within the
community. This year's Student Leadership Awards went
to Leah Bernstein, PhD, Emily Cronbach, MD, and
Alison Stuebe, MD.
Bernstein published two I1rst-author publications
and contributed ro a third during her graduate work in
neuroscience. Her thesis project focused on the locali za
tion and regulation of the so-called RGS proteins or
Regularors of G protein Signaling. Additionally, she has
been active in neuroscience education an d in student
government.
Cronbach is a summa cum laude graduate of
San Francisco State, with a bachelor's degree in 111m.
Prior ro entering medical school, she worked on several
documentaries related to teenagers and HIV. She was the
co-organizer of the Reproductive Options Education
program, a forum for debate on ethical issues in repro
ductive health, and she served as co-coordinator of the
stud ent cha pter of the American Medical Women's
Association (AMWA) , through which she developed a
fourth-year elective in outpatient women's health. She

was selected for Alpha Omega Alpha, the national
medical honor society.
Stuebe is a summa cum laude graduate of Duke
University who came to Washington Universiry after
a st int as producer for the New York Times online site
on women's health. She was award ed the School of
Medicine's Mr. and Mrs. Spencer T. Olin Fellowship for
Women, and also was selected for Alpha Omega Alpha.
Stuebe was instrumental in creating the School of
Medicine's career counseling web site, which she pre
sented at the 1999 American Association of Medical
Colleges (AAMC) national meeting. She was active as
co-coordinator of the student chapter of AMWA, and
served on the group's national web site task force.
The AWN presented its 2001 Mentor Awards to
twO faculty members: Linda B. Cotder, PhD, and
Herberr W. Virgin IV, MD, PhD.
Cotder, professor of psychiatry (epidemiology)
joined the Washington University faculty in 1990. She
received her MPH from Boston University School of
Publi c Health in 1980 and her PhD from Washin gto n
University in 1987.
Virgin is an associate professor in medicine, in
molecular microbiology and in pathology and immunol
ogy. He received his MD/PhD from Harvard University
and joined the Washington University faculty in 1991.

Outstanding Student
Researcher
Third-year medical student Clint Walker
(center) receives the Alpha Omega Alpha
(AOA) 2001 Student Research Fellowship
Award from Scot G. Hickman, M0, (left)
professor of medicine and president of the
School of Medicine's AOA chapter. Walker
was awarded $3,000 in support of his
research on peripheral nerves. His advisers
on the project are fellow John Winograd,
MD, (right) and Susan E. Mackinnon, MD,
professor and head of the division of plastic
and reconstructive surgery.
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International
cooperation
William A. Peck, MD, executive vice
chancellor for medical affairs and
dean of the School of Medicine,
welcomes Clifford Nii Boi Tagoe,
MB, ChB, PhD, dean of the
University of Ghana Medical School,
during a recent visit. The two
medical schools, along with BJC
International Healthcare Services
and the Missouri Department of
Economic Development, discussed
potential collaboration regarding HIV
programs in Ghana, Africa.
Graphic: The HIV virion.

Neufeld recipient of Rudin glaucoma prize for work in protecting nerve cells
ARTHUR H. NEUFELD, PHD, the Bernard Becker

80,0 00 Am ericans with gla ucom a are legally blind from

Research Professor of Ophthalmology and Visual

the disease, and it is the No.1 cause of blindness in

Sciences at the School of Medicine, has been awarded

African Americans.

the 2000 Lewis Rudin Prize by the New York Academy
of Medicine. The Rudin Prize is given annua ll y for
outstanding glaucoma research published during the

Neufeld has received many grants from the N ational
Institutes of Health to suPPO rt hi s research. Currenrly,
he is principal investigaror on the granr, "Pharmaco
logical Neuroprotection in

prevlOus year.
Neufeld showed that protecring reti nal nerve cells can

Glaucoma, " which has been

help p revem damage in a chronic model of glaucoma.

helping ro suppOrt his

In a 1999 paper in the Proceedings ofthe NationaL
Academy ofSciences, Neufeld and colleagues reported on

NOS-2 in the eye.

research aimed at inhibiting

experiments involving an anima l model of glaucoma.

Over the last two

\X!orking in rats with elevated eye pressure, they were

decades, Neufeld has served

able ro prevenr loss of retinal ganglion cells by inhibiting

the Eye Research Institute

the action of an enzyme that makes nitric oxide .

of Retina Foundation in a

With co-authors Akira Sawada, MD, and Bernard
Becker, MD, N eufeld demonstrated that an agem ca lled

Arthur H. Neufeld, Phil

variery of capaci ties, including
direcror of research. He also

aminoguanidin e significanrly limited retinal ganglion cell

is a member of the Glaucom a Foundation's Scientific

loss. Aminoguanidine inhibits the acriviry of the enzyme
that makes nitric oxide, called inducible nitric oxide

Advisory Board. He sits on the editoria l board of the

Jo urnaL of OcuLar PharmacoLogy and Therapeutics , and he

synthase (NOS-2).

is a longtime member of the Association for Research

G laucom a, a disease in which patienrs first lose
peripheral and then central vision, affects more than

in Vision and Ophthalmology, servin g both as a trustee

3 million adu lts and is the second-leading leading cause

and as that gro up's president in 1984.
Th e Rudin Prize was established in 1995 and is

of irreversib le vision loss in th e United States. More than

funded by the Sa muel and May Rudin Foundation .
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New Center for Advanced Medicine
names Walker, Tucker co-directors
ROSE A. WALKER AND KIMBERLY TUCKER

will team up to direct the Center for Advanced Medicine
(CAM), the new ambulatory care center scheduled
• to open in November 2001.
Walker will represent the
School of Medicine, and
Tucker will represent
Barnes-Jewish Hospital.
In her new position,
WaJker will coordinate clinical
operations and policies with
the 14 clinical centers housed
in the Center for Advanced
Rose A. Walker
Medicine. She will work with
Tucker on issues that cross institutional and departmental
management lines, such as service issues affecting patients.
As a liaison, she will assist patients or faculty members
with concerns that arise among departments or between
the medical school and the hospital.
Walker, who played a critical role in developing
the Center for Advanced Medicine, also is director of
ambulatory operations
for the Facul ty Practice
Plan. She formerly worked
as a nurse clinician and a
nursing administrator for
inpatient and ambulatory
services at Barnes-Jewish
Hospital and as a physician
practice administrator for
the medical school.
Kimberly Tucker
Tucker will coordinate
the center's operational responsibilities related to Barnes
Jewish Hospital. She will establish standards of practice
and care and develop policies and procedures in collabo
ration with Walker.
A clinical manager, Tucker has been in management
at Barnes-Jewish Hospital since 1987. She earned a
bachelor's degree in nursing from the University of
Missouri-St. Louis, and she is completing a master's
degree in nursing from the Jewish Hospital College of
Nursing and Allied Health. Additionally, Tucker has
served in leadership roles for the American Association
of Critical Care Nurses and is a member of the American
College of Health Care Executives.
Outlook Summer 2001

Andrew C. Heath, PhD, professor of psychiatry, left, and Kathleen K.
Bucholz, PhD, research associate professor of psychiatry, talk with
psychiatry department chair and Samuel B. Guze Professor Charles F.
Zorumski, M0, at the inaugural symposiumnamed in Guze's honor.

First Guze Symposium held
E MISSOURI ALCOHOLISM RESEARCH
CENTER (MARC) recently hosted the first

Guze Symposium to discuss the latest in clinical
practice, research and treatment for alcoholism.
The Guze Symposium was named in honor of
the late Samuel B. Guze, MD, a pioneer of the medical
model of psychiatric illness and in the field of alco
holism research. His early studies of alcohol use and
abuse were important in the m ovement to consider
alcoholism a disease rather than a character flaw.
U / ,e joined the faculey in 19 51 and later served
as vice chancc.llor fo r medical affairs and president of
the Washin gton University Medical C enter from 1971
to 1989. He also served as head of psychiatry from
1971 to 1989 and again from 1993 to 1997.
The symposium featured local and national
experts on topics such as genetic studies of alcoholism,
the role of depression and anxiety di~o rders in alco
holism, treatment for alcoholism and drug abuse, and
the consequences of alcohol abuse by adolescents.
Created by a $6.7 million grant from the
National Institute on Alcohol Abuse and Alcoholism
(NlAAA) at the National Institutes of Health, the
MARC is one of 15 NIH-funded alcoholism research
centers.
Housed at Washington University, the center
also involves investigators from Saint Louis University,
University of Missouri-Columbia, St. Louis and
Palo Alto CA Veterans Administrati ons, and the
Queensland Institute for Medical Research in
Brisbane, Australia.
Pulse 7
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An age-related disease that
compromises your most
critical vision responds to a
promising new therapy
by Candace O'Connor

OR AN OLDER ADULT LIKE DOROTHY BEIMFOHR,

who loves

to

read and needs

to

drive, age-related

macular degeneration (AMD) is a terrifYing diagnosis .
"When I first heard that, it really just shook me," she says.
How would this eye disease-in which abnormal blood
vessels creep under the center of the retina, leaking blood
and destroying vision-change her life? Would it curtail
her pleasant visits to the Mascoutah, Illinois library?
Would it rob her of the sight of her five grandchildren?

Above: Dorothy Beimfohr, AMD patient.
Facing page: Do you take your percep
tion of a simple grid for granted?
Patients with macular degeneration
may lose the ability to clearly see
these lines-and the things they love
in life -even overnight.
8 I Can See Clearly Now

"When patients lose their center
of vision, you ca n't tell by looking at
them that they are handicap ped,"
says Nancy M. Holekamp, MD,
assistant professor of clinical oph
thalmology, who treated Beimfohr.
"But they won't recognize you
beca use they can't see your face, they
have a hard time dialing yo ur phon e
number and if you ask them to read
something, they can't. Consequently,
they lose a lot of their independence."

This disease, the leading cause of
blindness in people 65 and older, is
nOt only devastating for patientsit also is frustrating for their physi
cians. AMD sufferers, who otherwise
may be in perfect health, become so
desperate that they sometimes resort
to sham treatments in an attempt to
find a cure. And ophthalmologists,
armed with few clinical weapons to
fight the disease, have litde they can
do to help.
At the Barnes Retina Institute
(BRI), a national leader in retinal
research, Washington University fac
ulty members are involved in several
clinical trials that are testing new
therapies aimed at saving or restor
ing vision in AMD patients. In fact,
BRI faculty members have partici
pated in most of the major trials that
have taken place over th e past several
decades. A recent trial that examined
a new approach (0 treating AMD,
photodynamic therapy, has shown
promising results.
Summer 2001
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W nte
center
of sigh
fails
The center of the retina, called the macula,
is highly detail-sensitive, allowing you
to read this page or recognize your friend's
face. Macular degeneration attacks this
critical area of vision.

AM 0 comes in two basic forms. The "dry"
type is characterized by spots called driisen
and sometimes by atrophy of the tissue
layer that underlies the retina . No treatment
exists for dry AMD, but H is also a milder,
more slowly progressive disease that only
accounts for 10 percent of severe vision loss
among AMD patients.

Searching for
effective treatment

Healthy retina

Appearance of "age
spots" call ed driisen

"Wet" AMD
The story is much different with the second,
"wet" form of the disease, in which blood
and fluid from abnormal blood vessels leak
onto sensitive photoreceptors in the macula.
Among AM 0 patients, this type of the dis
ease accounts for 90 percent of all severe
vision loss. Often, this change occurs sud
denly, without warning.
It is not yet known exactly why this
happens. Attempts to link AM 0 to smoking
or diet have not been successful. It is rare
in Asian and African-American patients and
most common in women 60 and older of
Scandinavian descent. There may be a
hereditary component to the disease -but
what stands out is its correlation with age.
The longer you live, the more likely you are
to develop it.

Macula with wet macular
degeneration (abnormal
blood vessels) impedes
central detail vision

"We see thousands of pa tients a yea r
with macular degeneration; they make
up at leas t 25 percent of o ur case
load," says M. Gilbert G rand, MD,
p rofessor of cl inical ophthalm o logy.
"Th is is a very sig ni ficant problem,
and we are continuing ro see more
of it as the popu lation ages. Among
th e sadd es t aspects has been having
ro tell patien ts that we have limited
forms of trea tment."
In the late 1980s and early
1990s, Washingron University an d
o ther institutions particip ated in
the Macular Phorocoagulati on Study,
sponsored by the Na tionall nsti(Utes
of Health, which targeted patients
wi th wet AMD. Th e firs t p hase of this
trial foc used o n pati ents whose blood
vesse ls had pene trated the macula
but had not yet reached th e fovea,
its tiny, 500-micron-wide cenrer.
In the stu dy gro up, clinic ians
used a conventional, therma l laser
ro destroy the vessels; in the con tro l
gro up, pa tients did not receive laser
trea tm ent. T he res ults showed th at
lase r therapy was effective, but it
was not a perfect sol ution. Nearly
50 pe rcent of the ti me the vessels
grew back-and the laser was
dest ruc tive, creat ing a blind spOt
where it did its work.
St ill, the results we re posit ive
enough t hat researchers went fu rth er,
studying pa tie nts whose blood ves
sels ha d grown inro the fovea. T he
laser treatment again yield ed m ixed
resu lts. It destroyed th e blood vessels
and stymied their regrowt h, but it
also destroyed the cente r of vision,
rendering pat ients legally blind . Eve n
so, 18 months after trea tment, the
trea ted pa ti ents were better off t han
th e u ntreated contro l group.
Summer 200 1 Outloo k

blood vessel s without hurting the
retina, which is a huge advantage."
The treatment is easy, quick
and painless. The trick is to catch
patients when they are just begin
ning to lose vision, since those who
have had the disease for years and have formed retinal scar tissue
-will not benefit from any cUlTenrly
available treatment.
Retina specialists initial1y per
form a fluorescein angiogram test to

Nancy M, Holekamp, MO, examines the eye of patient Sametta House,

About the same time, two
Washington University ophthalmol
ogists-Matthew A. Thomas, MD,
of the BRI, and former department
head Henry]. Kaplan, MD
pioneered an extraordinary form of
surgery in which they elevated or

Photodynamic therapy
may be one answer

When Beimfohr came in for
her PDT treatment, she received a
I O-minute infusion of photopor
phyrin dye, Visudyne™, into a vein
in her arm. The d ye coursed through

focally detached the retina, plucked
out the errant blood vessels, and then
put the retina back in place. A mul
ticenter clinical trial cu rren rly in
progress, with Thomas as national vice
chairman , is evaluating the success of
this surgery, but it appears so far that
it works best in younger patients.

which a non-thermal laser targets
leaky blood vessels.
Washington University partici
pated in the clinical trials of PDT,
which was approved by the FDA in
April 2000 for one form of AMD.
Already, BRI physicians use it daily,
and that usage may soon increase,

all the blood vessels in her body,
including the abnormal vessels in
her retina. Then Holekamp shone
the non-destructive laser at her eye
for 83 seconds. Throughout the
procedure , Beimfohr was fully
awake; afterwards, she only had to
avoid direct sunlight for five days.
Following treatment, ophthal
mologists re test PDT-trea ted patients
at three-month intervals to deter
mine whether any regrowth has

Other trials are ongoing. A
national, NIH-sponsored study-the
Complications of AMD Prevention
Trial (CAPT)-with Grand as prin

since the FDA is on the verge of
approving its use in other forms of
AMD. In addition, PDT has strong

occurred. If it has, they repeat the
treatment.
Beimfohr was fortunate - not

potential for treating patients with
other retinal diseases .
Beimfohr is delighted with the
Outcome of her PDT treatment .
While many patients have bilateral
disease, her left eye has not been
affected . Bu t the vision in her dis

only did the photodynamic therapy
prevent the abnormal blood vessels
from returning, h er vision actually

cipal investigator, is studying the
use of low-power laser to treat dry
AMD, which can be a precursor to
the wet form of the disease.
BRI physicians also are
participating in a study of macular
translocation surgery, developed
at Johns Hopkins. And they are

But the latest and most promising
form of AMD treatment is the

determine which patients are eligible
for PDT treatment.

photodynamic therapy (PDT) that
Dorothy Beimfohr underwent, in

eased right eye has improved from
20-80 to 20-40- enabling her to

enrolling patients in a trial spon
sored by Alcon Research , Ltd. , to
see wheth er a new compound,

drive once again.
" PDT is an ingenious idea," says
Holekamp. "The eye is set up per

anecortave acetate, StopS the leakage
from these abnormal blood vessels.

fecdy for this type of novel therapy.
And it only destroys the abnormal
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improved.
In the clinical trial of PDT,
67 percent of patients who received
the treatment were stabilized or
improved by it. Only 16 percent,
however, had a return of good vision.
"So it is not the cure that we
were hoping for," says Holekamp,
" but it is something else that we
have to offer patients who otherwise
have no hope." 0
I Can See Clearly Now
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1990,

Heidi Beddingfield was a carefree I8-year-old, still
feeling the invincibility of youth. "I expected I only had
three years to live, but it didn't bother me," she says.
"After all, what could I do about it?"
She was right-there wasn't much that could be done at the
time. The few available drugs could only be expected to control the
virus for about a year. Besides-it was too much of a hassle for
the teenager to deal with grinding up multiple pills every day and
sticking to a strict regimen.
In a way, she was lucky. Beddingfield's virus didn't
Rare up until December, 1995. Overnight, she went
from feeling invincible to becoming incapacitated
by a bacterial infection that attacked her brain, a not
uncommon consequence of an immune system weak
ened by HIV Fortunately, by that time, scientists
had just discovered a new way to treat the disease:
by combining three classes of medication.
After five weeks on this triple-drug cocktail,
Heidi Beddingfield, infected with HIV for
more than 10 years, discusses her health
with William G, Powderly, MO, clinical
director of the AIOS Clinical Trials Unit
(ACTU) at the School of Medicine,

Beddingfield's viral count decreased drastically; after a couple more
weeks her virus qualified as "undetectable." Six years later, her AIDS
is still under control.
But there's a catch. In 1998, Beddingfield started to dramatically
lose weight. Her body is wasting away, and doctors now suspect the
very drugs saving her life are to blame.
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J / hen the first cocktail component (nucleoside
analogs, such as AZT) was introduced in 1987,
scientists were optimistic. But patients with human
immunodeficiency virus (HIV), the precursor ro
acquired immunodeficiency syndrome (AIDS), sropped
responding ro the medication after just one year of
contlnuous use.
In the following yea rs, twO new classes of drugs were
quickly approved by the FDA: non -nucleoside reverse
transcriptase inhibirors and protease inhibitors. By 1995,
the FDA recogn ized that combining drugs from these
three classes crippled the virus' ability ro replicate . The
resulr: highly active antiretroviral therapy (HAART),
commonly known as the AIDS drug cock tail.
Thanks to the cocktail, people with AIDS now are
living considerably longer an d healthier lives than before.
But the treatment fall s shOrt of physicians' initial expec

Steven L. Teitelbaum, MD ,with fellows Michael Wang, MD, and Patrick Ross, PhD.

tations. The new drugs
may be able to control
the virus, but they
cannot eliminate it.
Resea rchers have thus

" ... the body

patients on the cocktail. If these effects, collecti vely
termed lipod ys trophy, cominue to intensify as expected,

far conceded that

...over

researchers predict persons taking the cockeail will even

the course of

complications such as diabetes, heart disease and stroke.

the disease "

the disorder's three main symptoms: insulin resistance,

ruall y experience a marked increase in life-threatening

remain on medication
And, as has happened
with the first cocktail
component when taken

Patients with lipodystroph y exhibit at least twO of
the precurso r ro diabetes; high triglycerides or choles
terol, which often leads to h ea rt disease and stroke; and

alone, con ti l1UOUS long
term use of th e cocktail

changes, such as insulin res istance and high cholesterol;
roday, these changes are found in roughly half of all

tokes

patients will have to
for the rest of their lives.

starred ro notice a d ange rous pattern of metabolic

Kevll1 E. Yorosheski , PhD

could result in the devel

a unique pattern of fat distribution. Patients with the
disease lose fat from their extremities and their faces,

opment of drug-resistant strains of the disease, if patients

and they gain fat inside the abdomen itself, instead of

don't adhere strictly to the drug regimen.

just below th e skin surface and outside the abdominal

The drugs also may not be risk-free, as previously

wall, as in normal weight gain.

thought. As patients like Heidi Beddingfi eld live longer
with the disease and spend yea rs taking these drugs,
new problems arise.
"Not un til my body started to change did I reall y
feel all the rhings AIDS robs you of," says Beddingfield,

1-

he exa ct cause of lipodystroph y is unclear. What
is known is that HIV makes copies of itself which

then invade other cells. The virus recruits each corrupted

"you r dignity, yo ur self-es teem, your appearance and

cell along the way in a pattern of continuous replication .

your physical well-being."

As patienrs live longer with the cocktail's help, the virus

It's that las t quality-physical well-being-that her

has more time ro wreak havoc. Also, many HIV-positive

School of Medicine physici ans are focusing on. For 14

patienrs are co-infected with other diseases such as

years, the university's AIDS Clinical Trials Unit (ACTU),

Hepatitis B. As they survive longer, these secondary

part of the largest consortium of AIDS research centers

infections also have more time to affect metabolism.

in th e world, has been ar the forefront of developing new
therapies. In 1997, experts here and at other cemers
14 The Cocktail Conundrum

But neirher of these theo ties fully explains the
sudden increased incidence of lipodystrophy noted in
Summer 200 1 Outlook

the past few years, coincident with introduction of the
third cocktail component, protease inhibitors.
"We believe that the body takes a series of hits,"
explains Kevin E. Yarasheski, PhD, associate professor
of medicine, "and that the toxic effects of the anti-HIV
drugs and infection with HIV accumulate over the
course of the disease." Scientists propose that protease
inhibitors in and of themselves do not cause lipodystro
phy. But, when taken in conjunction with this sequence
of "hits," they may trigger undesirable physical and
biochemical changes in the body.
Researchers at the ACTU decided to take action.
William C. Powderly, MD, co-director of the division of
infectious diseases and professor of medicine, assembled
a team led by himself, Yarasheski and Samuel Klein, MD,
the Danforth Professor of Medicine and Nutritional
Science, to investigate this emerging problem. The team
plans to analyze muscle and fat tissue samples from
lipodystrophy patients and compare them with samples
obtained from HIV-infected individuals who are not
experiencing metabolic changes. They also will examine
the contribution of protease inhibitors to these metabolic
changes by carefully altering the components of the
cocktail in certain individuals experiencing side effects.
Further insight into the lipodystrophy phenomenon
may provide new hope for patients infected with HIV
and for non-infected individuals with diabetes, high
cholesterol or triglycerides, or abdominal fat.
"If we determine the mechanisms underlying the
cause of lipodystrophy in HIV-infected patients, we
may be able to develop specific therapies for these com
plications or, even better, help to design drugs that target
the virus but avoid these effects," says Powderly. "The
other spin-off is that this is a model system for very
common disorders, such as d iaberes and high cholesterol,
in individuals who are not HIV-positive. We can use
these new drugs to gain a glimpse of metabolic processes
in normal, healthy individuals that we otherwise might
not have found."
Washington Universiry researchers already have
made the novel discovery that patients who receive the
drug cocktail are more susceptible to bone softening,
such as that which occurs in osteoporosis. Steven L.
Teitelbaum, MD, the Wilma and Roswell Messing
Professor of Pathology, specializes in the basic science
aspect of bone research. Already he is using information
from the ACTO's clinical research to study the effects of
HIV on bone cells in mice.
Outlook Summer 2001

The School's clinical AIDS care could
soon stretch from St. louis to Ethiopia
Washington University School
of Medicine not only has one
of the leading AIDS research
programs, it also serves the
St. Louis community through
various outreach efforts.
One example is the Helena
Hatch Special Care Center for
women with HIV, which has
become a nationally recognized
center of excellence for com
prehensive HIV care and clini
cal investigations of HIV among
women.
Soon, the School of
Medicine's influence may reach
as far as Africa, where avail
ability of the latest medications
and information is still scarce
despite the fact that more than
25 million people there are
now infected with HIV.
David B. Clifford, M0,
and his African research fellow,
Enawgaw Mehari, M0, recently
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returned from a trip to
Mehari's home country,
Ethiopia, where they discussed
plans for a clinic at the
University of Addis Ababa. With
funds from organizations such
as the World Bank, the United
Nations and the National
Institutes of Health, the team
hopes to establish a center at
the university where they will
mentor Ethiopian physicians
and establish a basic AIDS
therapy program.
"We're excited about the
possibility of setting up a clinic
which will be a practical help
to people who are in desperate
need," says Clifford. "Ever the
academician, I also am eager
to have the opportunity to
learn more about this infection
in a different cultural popul'a
tion. We're hopeful that it will
be a very rewarding project:'
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Ethiopian artist Afewerk Tekle created "Unity Triptych," internationally
famous stained-glass windows that confront visitors in the entrance of
Africa Hall, headquarters of the United Nations Economic Commission for
Africa, in Addis Ababa, Ethiopia, if~e piece embodies in three panels Africa's
sorrowful past, present struggles and high aspirations for the future,
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uring the first five years of living wi th her disease,
Heidi Beddingfield neglected to take her medications.

Even with today's improvemenrs in AIDS therapeutics,
she ingests a grueling regimen of 30 pills a day. Imagine
how much more difficult it would be to keep up with
this rigid schedule for patienrs who also are developing
neurological symptoms such as memory loss or attention
difficulties.
Despite treatment advancemenrs, some patients are
faced with this added challenge. Within days of being
infected with HIV, the virus spreads into the central
nervous system (brain and spinal cord) and into periph
eral nerves. In fact, it is puzzling that only some patients
experience the effects of nervous system damage. By
understanding these symptoms and determining how
and when they arise, researchers hope to improve their
basic understanding of AJDS and to develop new ways
ro treat the infected nervous systems.
Just as in lipodystrophy, some neurological effects of
HIV may be exacerbated by the roxicity of medications.
For example, peripheral neuropathy-chronic, disabling
pain in peripheral nerves such as those in the feet-actu
ally worsens with treatment of the virus and is estimated
ro affect at least 30 percent of patients with AIDS. In
conrrast, the incidence of central nervous system disor
ders has decreased since the cocktail was introduced,
from roughly 65 percent ro less than 10 percent.
"The numbers are down, but it's still a serious prob
lem, " says David B. Clifford, MD, the Seay Professor
of Clinical Neuropharmacology in Neurology and vice
David B. CliHord, MD, left, confers with research fellow Enawgaw Mehari, MD.

chairman of neurology. "Our main concern is what
will happen next, because we know this is an area where
the virus is JUSt waiting to spring back and where our
therapies are incomplete."
The central nervous system arguably presents the
biggest challenge in understanding how to reach the
virus and halt its destructive effects. Medications have a
difficult time getting into the brain because of its natural
protective shield, the blood-brain barrier. Also, scientists
suspect that HIV attacks the brain and spinal cord in
a slightly different fashion than the rest of the body.
Clifford therefore is examining the cerebrospinal
fluid-fluid that fills the spaces around the spinal cord
and in the brain-from HIV-positive patients. He plans
to measure the activity of the virus in the central nervous
system as cognitive performance changes and hopes
ro determine the effectiveness of HIV medications in

penetrating and helping the nervous system.
Another unique challenge is that brain cells are more
sensitive to changes in their environment than other cells
in the body. According
If

HIV i.s

ollymole .. "

to Clifford, cognitive
decline may result from
the sheer presence of
infected immune ceJJs
that release chemicals

not normally found in
the brain environment.
His team currently is

testing a promising drug
called selegiline that may
Pablo Tcbas, MD
help protect nerve cells.
" Because we can't yet eradicate the
disease, there is a low-grade infection in
the brains of all patients with HIV," says
Clifford. "We are concerned that as
patients live longer, they may be subject
an accelerated degenerative disease ,
similar to Alzheimer's."
to

Despite these hurdles, one fact
remains: These drugs save lives. According
ro Pablo Tebas, MD, medical director
of the ACTU and assistant professor of
medicine, "HIV is not a death senrence
anymore. There is a trade-off in everything
in life, and medicine is no exception.
But the benefits of understanding the
side effects of therapy will be global." 0
16 The Cocktail Conundrum
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Above: Robert 0, Schreiber, PhD, has spent the
past eight years exploring whether the Immune
system is involved in tumor formation, He led the
study; Vijay Shankaran, M0, PhD, was first author.
Below: The enemy within : tissue samples from
breast and intestinal tumors,
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Colds and cancer are
different, right?
But shouldn't the body's

~

defensive gatekeeper
the immune system
guard against both?
Research stood in the
face of common sense
until now.
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The Immune System vs. Tumors

- -

C

the throat or ca lm an aching
tummy, but the immu ne

sys tem ultimately is the body's rea l
hero, scou ring it for danger and
defe nding it against suspect cells.
Bu t w hat abou t tumor cells? Does
the imm une system also protect
aga inst these often dead ly enemies?
For years scientis ts expected it
did . Bu t studies in the 1970s found
th at "nude" mice - th ose tho ught
to lack imm une cel ls called lym pho
cytes - d id nOt develop more c hemi

cally in d uced or spontaneous tumors
th a n n orm al m ice. The imm un e
sys tem theory was largely aban do ned .
Bu t so me researche rs co nti n ued
to sea rch for a ro le o f th e im mu ne
sys tem in tu mo r develo pm e nt,
d ete rm in ed to bridge the gap
bewee n im m un o logy and o ncology.
To that end , Ro bert D. Sch reiber,
PhD , the Al umni Professor of
Parhology an d Imm un ology and
p rofessor o f m o lecul ar microb iology,

J.

Kettering Can cer C enter in N ew
York. Schreiber is know n fo r his
research on interferon-gamm a (I FNy),
an important protein in th e im mun e
system, while Old is con sidered
by many to be the grandfath er o f
tumor immunology. With help
from a team of School of Medicin e
researchers, the pair h ave determi ned
that the immune system does in
fact appear to protect agains t
rumor form ation .
Combined wi th mo unting
evidence in the fi eld , it's a discovery
th at could red irect the pu rs uit o f
ca ncer therapies a nd o ur under
standing o f how th e hum an bod y
res po nds to infecri o n.
18 The Immune System vs. Tumors
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Four key findings: The immune system eliminates

HI CK EN SOUP may soot he

for med a co llabo rat io n with Lloyd
Old , MD , director and CEO o f
th e Ludwi g Institute for Ca nce r
Research at Memori al Sioa n
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chreiber's team first examined
whether mice lacking lymphocytes
developed tumors when exposed to a
chemical carcinogen. To do so, they devel
oped a strain of mice that definitively
lacked functional lymphocytes. This was
accomplished by inactivating a gene found
in all lymphocytes, RAG2.
They then injected the chemical car
cinogen MeA into a group of mice lacking
RAG2 and into a group of normal mice.
Only 19 percent of normal mice developed
tumors, in contrast with 58 percent of
RAG2-deficient mice.
In previous studies, the group exam
ined the effect of MeA on mice lacking
either the receptor for IFNy or one of
the proteins required for the receptor to
function, Stat1. Roughly half of these
mice also developed tumors.
In their current study, the researchers
also generated mice with two disrupted
genes-the gene for RAG2 and the gene

The first two findings show that both
I IFNyand lymphocytes interact with
one another to protect individuals
from cancer development. That's the
good news.
But there's also bad news.
Tumors that developed in normal
mice due to injection of MeA were later
transplanted into healthy mice. The tumors
continued to grow.
Tumors from RAG2-deficient mice
also were transplanted into healthy mice.
Eight out of 20 of these were rejected.
Apparently, the immune systems in
healthy, carcinogen-free mice were better
equipped to recognize-and reject-tumor
cells that developed in RAG2-deficient
mice (in the absence of a healthy immune
system) than tumor cells that had devel
oped in mice with intact lymphocytes.

for Stat1. When these doubly-deficient
mice were injected with MeA, 72 percent
of them developed tumors. Statistically,
this was not greater than the incidence
of tumors in mice that lacked just one
gene or the other. Therefore, the team
concluded that RAG2 and the IFNy receptor
have overlapping roles.
"We think the two are potentially
part of the same mechanism but represent
different steps in the process," explains
Schreiber. "IFNy makes tumor cells
expose themselves to the immune system.
After seeing the abnormal proteins in the
tumor, the Iympilocytes eliminate the
tumor cells:'

Lymphocytes and
IFNy help prevent
formation of
chemically induced
tumors
Even a healthy immune
system only catches
some tumors-those that
escape detection pose
a greater threat
"As a result of protecting the body,
the immune system paradoxically favors
the outgrowth of tumors that are less
likely to be recognized and killed by the
immune system," Schreiber says. "It's a
'survival of the fittest' scenario that
works against the host:'
His immunoediting theory may explain
this selective protection. "If immunoediting
is always occurring, it can have multiple
outcomes," he explains. "If you're lucky,
the outcome is protection. But if you're
unlucky, transformed tumor cells might
alter themselves so the immune system
can pick out only a few. The others
continue growing:'
Summer 200 1 Outlook
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some tumor cells, changes the characteristics of others.

O

nly some human tumors can be
directly blamed on chemical carcino
gens. Often, tumors develop spontaneously,
without any apparent trigger. So Schreiber
and colleagues examined whether lympho
cytes and Stat1 contribute to the natural
development of tumors in the absence of
a carcinogen.
Again, they studied three groups of
mice-normal, RAG2-deficient, and those
deficient in both RltG-2 and-Stall.
After 15 months, two of 11 nor mal
mice had noncancerous tumors and the
rest were tumor-free. On the other hand,
all 12 RAG2-deficient mice had developed
tumors, half of which were cancerous.
~

,
~

f

I
•
,
;

t
,~

t

~:11;;..

Lymphocytes and
IFNy help prevent ~____-..
formation of
pontaneous
umor

Particularly surprising was the fact
that mice lacking both RAG2 and Statl
seemed to get very sick very quickly. All
11 doubly-deficient mice developed tumors
well before 15 months. Moreover, six devel
oped cancerous tumors in the mammary
glands. This type of cancer rarely occurs
in RAG2-deficient mice or in young mice
lacking the IFNy receptor.
At first glance, the higher threat of
developing spontaneous tumors in doubly
deficient mice seems to contradict the first
finding that mice lacking both genes are
not at a significantly greater risk of devel
oping chemically induced tumors. But IFNy
also plays a part in non-immune responses.
According to Schreiber, "while the roles of
lymphocytes and IFNy overlap, IFNy also
might prevent tumor formation via mecha
nisms not involving the immune system:'

GLOSSARV

he first Haw in the evidence
against the immune system
theory was revealed in the mid-1980s,
when two separate studies found
that nude mice were not in fact
completely free of lymphocytes, as
previously thought.
Schreiber and others later found
signs that both lymphocytes and
IFNy might play important roles in
tumor preventIon.
Now, in a paper published in
the April 26, 2001 issue of the journal
Nature, Schreiber's team presents the
first conclusive evidence that lympho
cytes and IFNy work together to find
and eliminate tumor cells.
When a role for the immune
system in tumor formation was
proposed decades ago, scien tists
envisioned a process called immuno
surveillance. Like a burglar alarm
that detects intruders, the immune
system was thought to patrol the
body, catching cells at the beginning
of their transformation into suspi
cious tumor cells.
In contrast, Schreiber and his
colleagues propose a new model
called immunoediting. Like the
security guard, editors catch errors
and delete them. They also adjust
and tweak areas that need smaller
alterations. According to immuno
editing, the immune system con
stantly eliminates certain types of
tumor cells and also changes the
characteristics of others.
"This sheds light on an age
old controversy and suggests new
possibilities for cancer therapy,"
says Schreiber. 0

lymphocytes White blood cells (immune cells)
that detect and kill foreign or diseased cells
RAG2 Gene found in all lymphocytes
IFNy Protein produced by lymphocytes that
helps the immune system

Stall Protein required for IFNy to function
TAPl Protein found in low levels in many
tumors that escape immune system detection
Doubly-deficient Mice lacking RAG2
and Stat1

/"

TAP1 can flag tumors
making them more
"visible" to the
immune system

S

ome tumors that escape immune
detection appear to have low levels of
a protein called 'fAP1. So the scientists
added this protein to tumors before trans
planting them into healthy mice. This, they
hoped, would trick the immune system
and allow for easier identification of
dangerous cells.
When highly aggressive tumors such
as those that managed to develop in mice
with a healthy immune system were
transplanted into healthy mice, they grew
in an extremely rapid manner. However,
when these tumors first were tagged with
TAP1 before being transplanted, they were
rejected.
Outlook Summer 2001
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When tagged tumors were trans
planted into RAG2-deficient mice, they
still went unnoticed. Thus, TAP1 facilitated
tumor detection and elimination only in
the presence of a healthy immune system.
"We showed that if a tumor is forced
to reveal itself to the immune system,
it often is rejected," Schreiber explains.
"We think that a tagged tumor could be
used to train the immune system to reject
others like it. This is very exciting because
it indicates that immunotherapy has a
significant potential use even for the
treatment of tumors that are altered by
the immunoediting process:'

The Immune System

VS.

Tumors
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U6ing a double d06e o~
medical 6kiLL and candor,
Donald V. Huebener, DDS, MS,
provide6 6pecia[-care dentiMry
brom cradle to "graduation."

BY DAVID
LINZEE

•

OR MANY CHILDREN, and indeed

has had plenty of experience putting children at
many adults, a dentist's office is a place
ease during his 30 years at Washington University.
of dread. But in the pastel-colored waiting
He takes Sean through his checkup step by step,
room
explaining
of
Donald
V.
Huebener,
DDS,
MS,
what he is about to do and rewarding
••
at St. Louis Children's Hospital, the mood is
cooperation with compliments. Soon the visit is
upbeat. Kids tryout the miniature chairs and Aip
over, and Sean bounds from the chair with a big
smile. ''I'm done!" he booms. "Thanks!" There
through pop-up books. They laugh and chatter
with their parents as if they were in line for a ride
remains only a visit to the prize drawer, from
at Six Flags rather than waiting to see the dentist.
which he selects a "stretchy alien guy."
Not all of Sean's visits go this smoothly, but
One teenager takes a nap in his sear.
When it is 9-year-old Sean's turn, he goes in
his strong relationship with Huebener has guided
him over the rough spots. "D r. Don is wonderful
to greet Huebener with a smile and a handshake.
with kids," says Godlewski. "When he explains
His mother, Dee Ann Godlewski, follows watch
fully. "He's always happy to see Dr. Don," she
firmly what has to be done, Sean will giddy up.
says, "but when the chair leans back, he gets
But he also has a soft touch when it's needed. "
nervous. It's only natural, after all he's been
A cleft palate can impair a child's hearing,
through."
speaking and eating.
Sean was born with
Huebener takes time
with parents, explaining
a cleft lip and palate, and
has had 18 surgeries in his
what he and other physi
cians and dentists must
young life. But Huebener,
professor of plastic and
do to correct problems.
"At each stage he's told
reconstructIve surgery
me: 'After this procedure
who supervises the four
Sean will get better,'
dental residents and two
Open wide: Huebener's cheerful high five helps relieve the
and he always does, "
assistants in pediatric
office-visit anxieties of children with special health care needs.
Godlewski says.
dentistry at Children's,
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four surgeries by the time she was 2 years old. She also
Children with serious medical conditions require com
plex treatment, of which dental care is an important
component. Unfortunately, it is often the missing com
ponent, because there are not enough dentists who are
willing and able to tackle the challenges of caring for a
special needs child. According to the American Medical
Association, dental care is the greatest unmet need of
these children.
Lisa Burbes could not find a dentist willing to treat
her infant daughter, Hope, until Huebener stepped in.
Hope had a congenital heart defect which would require

"

.
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Complex pediatric medical conditions
require the care of multidisciplinary spe
cialists, and teamwork is crucial, notes
Donald V. Huebener, 0OS, MS, with praise
for his School of Medicine colleagues.
"While, in general, medicine and denHstry
have grown up apart and had separate
schools of education, it's fortunate that
doctors from both disciplines work together
very closely at Children's," he says.
The manifold resources at St. Louis
Children'S Hospital and Washington University
make them outstanding facilities for the
very sick child. The Medical Center's
Cleft Palate and Craniofacial Deformities
Institute, which Huebener helped found,
currently treats more than 2,200 cleft
palate patients, as well as some 1,800
children with other head deformities. The
Institute brings together the many specialists
needed by these patients, including plastic
and oral surgeons, otolaryngologists, speech
pathologists, audiologists, pediatricians,
pediatric dentists, prosthodontists, ortho
dontists, nurses and team coordinators.
Care of cl'eft-palate patients begins
in infancy. As a plastic surgeon operates to
join the upper lip, Huebener, professor of
plastic and reconstructive surgery and of
pediatrics, custom-tailors an appliance
22 Smile Doctor

was prone to cavities. Left untreated, they could provide
a reservoir for contagion that threatened to spread.
"Dental caries (tooth decay) is an infectious disease,"
Huebener, professor of pediatrics, explains. "Bacteria may
go through the enamel into the dentin, then into the
nerve, and enter the bloodstream." If a child has a heart
defect, the bacteria may lodge there and create problems.
Hope now is 9 and has not needed surgery in five
years. But she still requires vigilant dental care, because
the re-routing of blood flow resulting from surgical COf
rection also may make the heart vulnerable to bacteria.
Hope doesn't mind the frequent visits. "She really likes

D

similar to a retainer. Inserted in the roof
of the mouth, the appliance helps correctly
mold and contour the palate. Further proce
dures are performed and other appliances
installed as the child grows, sheds baby
teeth and gains permanent teeth. Care
usually is completed when the
patient reaches the age of
19 or 20, and Huebener
and his colleagues
mark the occasion
with a "graduation"
ceremony.
Children with
other health problems
also require specialized
care. A child with epilepsy
may have a seizure while
06r'1
in the dentist's chair, so
Huebener must be ready
~"15tner
to prevent him from hurting
himself. In addition, some
drugs children take to control
seizures affect the central nervous system,
so he must be careful about the amount
of local anesthetic given for a procedure.
For a child with severe hemophilia, a
loose baby tooth is a potentially dangerous
problem. "If you just pull the tooth, the child
may start to hemorrhage, because the

Or.

blood won't clot," Huebener explains. "You
have to be careful even about giving local
anesthetics, because he may start to bleed
from the needle stick:' In such cases,
Huebener has to consult with the child's
pediatric hematologist about building
up the appropriate coagulation
factor in the blood before
he goes to work.
Children with
psychomotor distur
bances, who are
unable to stay still in
the chair, may require
sedation or general
anesthesia, and so may
very young children with
extensive caries. Cerebral
palsy patients also find it
."~pp~ difficult to keep still, but
Huebener has found that
by holding their heads
gently he often can work on them without
general anesthetic.
The complex medical cases he treats
provide Huebener and his colleagues with
the opportunity to meet unique professional
challenges. But it is his deft personal touch
that allows him to be both doctor and friend
to his young patients.

treats

(lIst6rner.

Summer 200 I

Outlook

in feeling exhausted, discouraged and hostile. He sat
down with her. "I told her, 'I'm here to help you in any
way 1 can. Your son's problems are my concern.' And as
we talked, all the negativity went away. Now we're the
best of friends."

I
PtA.tiet1(e is tJ,eir
rnid'Uer1tA.me
~"d 966d bl.fdd~
is tl1eir 9tA.rne."
- DONAlD y H UEBENE ~, DDS , ~1S
From the exam chair to the goody drawer,
Huebener keeps his young patients smiling,

D r. Don," Burbes explains as Hope selects her prize
(a ring, as usual). "His whole staff is good with children."
Infection spreading from dental caries also is a threat
to children with other medical problems. Before a child
can receive an o rgan transplant, surgeons require a clean
bill of oral health from Huebener. The drugs that pre
vent the immune system from rejecting the transplant
also lower the body's defen ses against bacterial infection.
Huebener's current patients include three receiving hearts
and on e receiving a double-lung transplant, along with a
number of children receiving liver and kidney transplal1ts.
Cancer patients need meticulous dental care before
and during chemotherapy, a treatment that causes their
white blood celJ count to go down, thus making them
vulnerable to infection. Huebener works closely with their
pediatric oncologists. "Any dental carc- an extraction,
a filling, even a rou tine cleaning, has to be timed with
chemotherapy," he explains.
Huebener sympathizes with parents who come to
him after a long day of trudging from one specialist's
office to another.
"They're overwhelmed with their child's problems,
and now they're being sent to still another doctor," he says.
He remembers one mother of a very sick boy who came
Outlook Summer 2001

Huebener believes in being completely honest with
parents. H e spends a lot of time with them, explaining
their child's condition and discussing treatment options.
Lisa Burbes, Hope's mother, notes that Huebener has
spoken several times to her support group for families of
children with heart defects.
Relationships with families of cleft-palate patients
like Sean Godlewski become especially close because the
course of treatment is long. "1 had a 16-year-old in today
whom I first saw as a baby," Huebener says. "Over the
years, you become a friend of the family." Parents call
frequently, seeking advice not just on medical care but on
such issues as whether their child with a cleft deformity
can go out for football or take up a wind instrument.

(, E T II N(, "A ST THE f EAI<
Asked the secret of his rapport with his young patients,
Huebener smiles and replies: "Pediatric dentists are also
psychologists. Patience is their middle name and good
buddy is their game." Contrary to popular belief, he
observes, fear of the dentist is not a normal part of child
hood. It arises because, all too often, parents wait until
children have a mouthful of cavities to take them for
their initial visit. Ideally, dental visits should begin when
the first baby tooth comes in. "You build a relationship
of confidence and trust, so that when you do have to give
them local anesthesia for a filling, it's not the end of the
world," Huebener says.
To put the young patient at ease, he talks as he works,
explaining what he is going to do and why it is necessary.
In this, he emulates his own fondly remembered child
hood dentist, who let him play with the "gizmos and
gadgets" in the office, and who made a dental checkup
an occasion to look forward to. His interest sparked,
Huebener went on to attend Washington University
School of Dental Medicine. The school, which closed in
1991, had a fine department of pediatric dentistry, says
Huebener, and it was the chair, Patricia Parsons, DDS,
who inspired him to make children his life's work.
"There's always something to look forward to," says
Huebener, "something I haven't seen before or helped a
patient with. That's what makes my job so fascinating." 0
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T' A MATCH! The annual match
day was held on March 22,2001, and
110 of the 123 graduating medical studen
took part in the National Resident Matching
Program (NRMP).
One hundred perc nt of the match day
participants secured a postgraduate uaining
po irion. Some 57 percent received fir t-year
residency positions at their first choice
of institution and 80 percent matched to one
of their tOP three choices. Eleven tudents
found positions independent of the NRMP.

i

Not just
another day

YEEESSSSSSIlI Hyung Kim unbridles his enthusiasm.
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OPHTHALMOLOGY

Joanna Oda

Phoenix

Sacramento

Barrow Neurological Institute

University of Califomia, Davis

tlEUROSURGERY

FAMILYPRACTICE/OB,
COMBINED

Pankaj Gore

L l

~O

NfA

Lorna Linda
Loma Linda University
ER MEOICINE

Tania Shaw

Melissa Marshall

Torrance
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Harbor-UCLA Medical Center

Chicago

Iowa City

ORTHOPAEDIC SURGERY

Chris Combs

Travis Air Force Base
David Grant Medical Center

INTERNAL MEOICltlE

TRANSITIO NAL

Vino Subramanian

Glen Macpherson

San Francisco

n 0

University of Califomia
San Francisco

Denver

0

University of Colorado

SURGERY. PRElIMltlARY

INTERNAL MEOICINE

Ma(( Abrahams

Deepu Nair

INTER NAL MED ICI NE

NEUR OLDGY

Kari Braun

Los Angeles
Kaiser Permanente, LA Program
INTERNAL MEOICINE

Peggy Shell
UCLA Medical Center

Andy Josephson

San Jose
Santa Clara Valley Medical Center
INTERNAL MED ICINE

INT ER NAL MEDI CI NE

Dora Ho

Lauren Burwell

INTE RNAL MEDICI NE, PRIMARY

oB/ GYN

Gina Serraiocco

Emily Cronbach
UCLA Neuropsychiatric Hospital
PSYCHIATRY

Joe Simpson
University of Southern California
DIAGNOSTIC RAOIOLOG Y

Hyung Kim

Stanford
Stanford University Program
GErIERAL SURGERY

Monica Tararia

Children's Memorial Hospital
PEOIATRICS

Amy Bobrowski
(Eldridge)
Zev Waldman
Rush Presbyterian /
St. Luke's/Cook County Hospital
INTERNAL ME OICI NE,
PRI MARY

Emily Engelland
University of Chicago Hospital
INTERNAL MEOI CINE

Shanika Samarasingh e
PEDIATRICS
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o
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MBfA

Washington
National Capital Consortium
Walter Reed Med ical Center
INTER NAL MEO ICINE

Amanda Weeks

o
Augusta

f

University of Iowa Hospitals
& Clinics
ORTHOPAEDIC SURGERY

Anthony Frisella
Mike Huang

o
New Orleans
Alton Ochsner Medical Foundation
Program
INTERNAL ME OICINE/ FA MILY
PRACTICE , CO MBINEO

Kevin Sterling

Juli e Bubeck-Wardenbutg

l

iJ

Bethesda
Indianapolis
Indiana University School
of Medicine
ER MEOIWIE

Ma(( POttS
St. Vincent Hospital
FAMILY PRACTICE

National Naval Medical Center
PEOIATRICS

Abigail H armon
National Capital Consortium,
Uniformed Services Program
OB/GYN

Belinda Blood

Amy Revelle

Medical College of Georgia
DERMATOLOGY

Dan Sheehan
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Boston

St. Louis

Beth Israel Deaconess
Medical Center

Barnes-Jewish Hospital

INTERNAL MEDICINE

Alice Hsu
Brigham & Women's Hospital
INTERNAL MEDICINE

Lynn Henry
OBI GYN

Alison Sruebe
Harvard/ Beth Israel Deaconess
NEUROLOGY

Jennifer Langsdorf
Harvard/MGH and Brigham
& Women's
NEUROLOGY

Bob Baloh
Massachusetts General Hospital
DIAGNOSTIC RADIOLOGY

Dan Cohen
Elena Karp
INTERNAL MEDICINE

Erhan Korngold
PEDIATRICS

Michael Kappelman
New England Medical Center

ANESTHESIOLOGY

oPHTHALM 0LO GY
Mohammed EI-Bash

Lawrence \'(1ang
Helen Kim

New York

DIAGNOSTIC RADIOLOGY

Hospital for Special Surgery

Wincha Chong
Judy Liu
Kevin Lee
Ann Young
INTERNAL MEDICINE

Ting-Hsu Chen
Linda Cheng
Jonas Cooper
Mary Doi
Tom Fong
Dusrin James
Rachel Presri
Shelby Sullivan
Holly Magiera
GeofF Uy
INTERNAL MEDICINE,
PRELIMINARY

Michael Lamb

Jonarhan Chun

Rob Brophy
Lenox Hill Hospital

Ron Gregush
Sandra KJein

Cindy Yeoh
New York Presbyterian Hospital
Columbia
OBI GYN

Tessa Madden
New York Presbyterian Hospital
Cornell
INTERNAL MEDICINE

Ann Tilley
INTERNAL MEDICINE, PRIMARY

Sonal Shah
New York University
School of Medicine
Laura Rymarquis

Rochester

DIAGNOSTIC RADIOLOGY

Paul Kim
ORTHOPAEDIC SURGERY

PSYCHIATRY

L -H I', " II
Ann Arbor
University of Michigan
ENT

Marc Thorne
OPHTHALMOLOGY

Serh Silbert

Detroit
Henry Ford Health
Sciences Center
ER MEDICINE

Amy Shirk

CHEERS!!! Carol Kaplan
is pleased-greatly.

Shawyon Shad man

Monica Bishop
Peter Fahnestock

PEDIATRICS

Karl Harrod-Kim

RADIATION ONCOLOGY

Lilie Lin
Parag Parikh
Sl. Louis Children's Hospital
PEDIATRICS

Jay Dri rz
Brian Saville
Colleen Wallace
Saint Louis University
School of Medicine
SURGERY, PRELIMINARY

Nik Chokshi
Washington University
School of Medicine

OR

CAnD

University of North Carolina
DERMATOLOGY

Erin Long

Durham
Duke University
INTERNAL MEDICINE

Marr Drake
NEU ROSU RG ERY

Lee Selzn ick

Devraj Basu
NEUROLOGY

Berh Leeman

A

Chapel Hill

ENT

Tim Beukelmall

Cleveland

l~lA~O

Providence
Rhode Island Hospital/
Brown University
ORTHOPAEDIC SURGERY

Cleveland Clinic Foundation
OPHTHALMOLOGY

Alben Dalcanro
University Hospitals of Cleveland

Ryan Calfee
PEDIATRICS

Archna Goel

NI=SSt:E

PEO IATRI CS

Joan Lee
Amy McBee (Davis)

Columbus

Nashville
Vanderbilt University
ENT

Ohio State University
Medical Center

Jeremy Vos

Shefali Gandhi
Riverside Methodist Hospitals

s
Dallas

University of Texas
Marianne Trorrer (Willey) Southwestern Medical School

FAMILY PRACTICE

University of Rochester/
Strong Memorial

PATH 0LO GY

PED IATRI CS

OB/GYN

PSYCHIATRY

Alben Ho
Brene Mendez

E

Cincinnati
University Hospital of Cincinnati

GENERAL SURGERY

OB/GYN
ORTHOPAEDIC SURGERY

with Diane Smith, student program coordinator.

ORTHOPAEDIC SURGERY

ER MEDICINE

Tracy Tomlinson

GENERAL SURGERY

Catholic MC of Brooklyn
& Queens

Ken Cummings

PEDIATRICS

Lahey Clinic

Flushing

DERMATOLOGY

Jessica Sachs

Burlington

NfW vDPK

GENERAL SURGERY
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Alan Harzman

Philadelphia
Children's Hospital of Philadelphia
PEDIATRICS

Lineo Thahane
Hospital of the University
of Pennsylvania
DERMATOLOGY

Aimee Payne
INTERNAL MEDICINE

Carol Kaplan
Scheie Eye Institute /
University of Pennsylvania
OPHTHALMOLOGY

Wai Wong
Thomas Jefferson Hospital
DIAGNOSTIC RADIOLOGY

Lauren Woodruff
University of Pennsylvania

Charlottesville
University of Virginia
GENERAL SURGERY

Shannon McElearney
(Tierney)

~I~GTON

Seattle
University of Washington Affiliated
Hospitals
INTERNAL MEDICINE.
PRELIMINARY

Jane Yoo
NEUROLOGY

Paula Gerber
OB/GYN

o

CHILD PSYCHIATRY (2002)

Hearher Bufford

Sharon Hasbani

PEDIATRICS

NEUROLOGY

Krisrin Welch

Akron

Josh Hasbani

Akron General Medical Center
ER MEDICINE

Jason Kolb
Summa Health System
ER MEDICINE

Samuel Lofgren

Pittsburgh
University Health Center
OB/GYN

Karhryn May
Western Pennsylvania Hospital

p
Deferring residency training
Aymen Elnky
Vijay Shankaran
Postdoctoral research
Daniel Pererson

SURGERY, PRELIMINARY

Tracy Allen
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Richard A. Blath

It's the 'little things' in life

Making a difference in the lives of individuals

BY RUTH
BEBERMEYER

T

HE "LITTLE THINGS" are the big reasons
The success of the residency program prompted
School of Medicine faculty to ask Blath to arrange a sur
why Richard A. Blath, MO '71, finds his work
gery clerkship for third-year medical students, the first
very satisfying. Those little things may be grate
such rotation at a hospital away from the Medical Center.
ful words from a patient whose cancer he has removed,
or a phone call from a couple with fertility problems
Two students per month participate, and the clerkship is
so popular that many more apply than can be accepted.
telling him the good news that the wife is pregnant, or
Blath takes pride and pleas
the appreciation of parents
whose child's birth defect
ure in helping residents and
students broaden their educa
he has corrected. They are
tion. He remembers apprecia
indications of the difference
tively his own teachers during
he makes in the lives of
studen t and residen t days at
individuals. His other
achievements and the lead
Washington University. Two
who particularly inspired him
ership roles he fulfills are
notable, but he views them
were now Professors Emeritus
Charles Manley, MO, HS '63-'67,
as incidental to caring for
the first pediatric urologist in
his patients.
Blath, a urologist and
St. Louis, and Robert Royce,
MO '42. Blath calls Royce the
surgeon, is Chief of Staff at
"ultimate professional whose
Christian Hospital NE-NW
in St. Louis and managing
clinical skill and bedside manner
Dr. Blath
partner of St. Louis
you strive to emulate."
A loyal alumnus ever since,
Urological Surgeons, Inc.,
a nine-member group with
Blath served as president of the
five offices in the metro
Washington University Medical
Center Alumni Association
politan area. The group,
a pioneer in the early use
during 1995-96 and as a mem
of brachytherapy in the
ber of the Executive Council
Midwest for men with
for a number of years. He has
prostate cancer, has treated
chaired class reunions and is a
member of the Eliot Society.
more than 300 such patients.
Before the approxiRichard A. Blath, MD '71, urologist and surgeon
mately 500-n1ember medical ............................................................................................................. -,..
a child, Blath suffered
staff at Christian Hospital elected him chief three years
from asthma and many
respiratory and ear infections, which required frequent
ago, Blath, a Fellow of the American College of Surgeons,
visits to his pediatrician, whom he respected greatly. That
chaired the department of surgery there for 10 years.
During that time, he initiated with Washington University
experience influenced him ro choose medicine as his own
School of Medicine a rotation for surgery residents that
career. He attended Miami University in Ohio, which
provides a wealth of training in general, vascular and
had a cooperative agreement with Washington University
trauma surgery. Residents have often rated it among the
permitting students to enter medical school after three
best of their experiences.
years of undergraduate work. He was inducted into

A

26 Alumni & Development

Summer 200 I Outlook

A s health care d elivery has become more complex and
more third parries are invo lved , Blath devotes more
time to parti cipation on policy-making bodies where he

.r-l.

can be an advocate for patients and physicians. He chairs
the Medical Executi ve Committee at Christian Hospital
and is one of five representatives from Christian who
sit on the Board of Directors of BJC. (He is the only
independent private practice physician on that bo ard .)
Christian Hospital President Paul Macek comments that
the hospital is "fortun ate to have someone of Dr. Blath's
caliber in key leadership positions" and describes him

_11 u.M¥

.
ect (d pe~d i.at ClaD

inspired Blath's career.
Phi Beta Kappa during his third year, and graduated cum
Laude after com pleting the first year of medical school.
After receiving his medical degree in 1971, Blath
did a general surge ry residency at Vanderbilt University
and a urology residency at Barn es Hospital, where he was
chief resident. Th en he spent two years as a major in the
United States Air Force, as chief of the Division of
Urology at Wright Patterson Air Force Base in Dayton
OH, and assistant professor of urology at Wright State
University School of Medicine. Back in St. Louis in
1978, he joined St. Lo uis Uro logical Surgeons and has
been on the staffs at Christian, DePaul and St. Luke's
hospitals since. H e sees patients of all ages for the gamut
of urological problems and does a great deal of treatment
for infertility. H e has been actively involved in RESOLVE
of St. Louis, a national society that provides education
and reso urces to infertile couples.

as "a trusted adv iso r in deali ng with the challenges we
face." Blath also serves on ph ysician advisory panels
of several m ajor health in sure rs, including Blue Cross
and United Health Care.
With all this, the best part of Blath's day is "coming
hom e to Lorry," his wife , whom he describes as "the cre
ative one." A gourmet cook, an artist and a writer, she is
currently working on a "semi-autobiographical" nove l.
The rabbi who married them in 1969 declared it a
"m arri age made in heaven" because they met in Lambert
Airport when both were students returning to Miami
University after the winter holidays. She h ad visited her
parents in Amarillo TX, and had to change planes in
St. Loui s, Richard saw her struggling to carry her new
stereo, went to assist, and they sat together during th e
fli ght. The rest is family history, which includes a married
daughter livi ng in Columbus who is the mother of their
twO grandsons, and a son, an artist li ving in Rhode Island .
A lover of adventure, Blath once spent hi s vacation
o n a ca ttle drive in Wyoming (as a boy, he wanted to be
a cowboy) . He has gone whitewater rafting on the Salmon
River and in Costa Rica, skiing in Aspen and elsewhere.
Las t year he and Lorry went on safari in Africa, spending
time in Zimbabwe and Botswana, a trip that allowed
him to practi ce his considerable
photographic sk ills, He also plays
golf "poo rly," and , perhaps to
ass ure that he will take time out
of his busy life to smell the
prove rbial roses, he grows more
th an 25 varieties in the backya rd .
Above: Richard A, Blath, MD, instructs
third-year medical student Caitlin Aveyard,
Left: While on African safari, Richard and
Lorry Blath visit breathtaking Victoria Falls
in Zimbabwe.
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David Clayson

Supporting research for ALS

Alumnus endows neurology chair
ALUMNUS DAVID CLAYSON, PHD, has bequearhed

a professorship in neurology ar Washingwn Universiry in
Sr. Louis. The chair will bear his name.
The annOllncemenr was made by Mark S. Wrighwn,
PhD, chancellor ofWashingwn University, and William
A. Peck, MD, execurive vice chancellor for medical affairs
and dean of rhe School of Medicine.
'

....-..-

I.:

..

,

"f

"Dr. Clayson's generous conrriburion w me Depanmenr
of Neurology demonsrrares his lifelong commirmenr w our
universiry," says Wrighwn. "We are honored rhar his name
will be associared wirh Washington Universiry in perperuiry."
Clayson, who suffered from amyorrophic lareral
sclerosis (ALS), more commonly called Lou Gehrig's
disease, died on April 10, 2001.
"I was impressed by Dr. Clayson's enrhusiasm and
compassion for orhers in rhe face of his own devasraring
illness," says Peck. "His dedicarion will help us recruir
and suppon wp faculry, reinforcing our rradirion of
excellence in medical research."
28 Alumni & Development

Clayson received his docwrare in psychology from
rhe College of Am and Sciences in 1963. He esrablished
rhe professorship w SUppOH scienrisrs whose research is
relevanr w developing effecrive rrearmenrs of ALS and
orher neurodegenerarive diseases.
"I am saddened by Dr. Clayson's rerrible illness
and dearh, bur grareful for his humaniry and generosiry
in making rhis wonderful gifr," says Dennis W .
Choi, MD, PhD, Andrew B. and Grerchen P
Jones Professor of Neurology and head of
neurology ar rhe School of Medicine.
r
Clayson was emerirus professor ar rhe Weill
Medical College of Cornell Universiry where he
served as a menror, adminisrrawr and researcher
for more rhan 38 years. He was head and direcwr
of clinical rraining of psychology in psychiarry ar
rhe medical college for 25 years.
Clayson was co-founder and charrer presidenr
of The Associarion of Professors of Psychology in
Medical Schools, rhe nrsr narionwide organizarion
of irs kind in rhe Unired Srares and Canada. He
also had been prominenr in srare and narional
organizarions for psychology professionals and was a
cOI1Sulranr ar rhe Memorial Sloan-Kerrering Cancer
Cenrer and ar The Hospiral for Special Surgery.
Based on his own research, Clayson wrore exrensively
on rhe psychological effecrs of orrhopaedic surgery in
adolescenrs and children.
The legacy he leaves wirh rhis professorship mirrors
Clayson's lifelong dedicarion w reaching. He was
rhe nrsr recipienr of rhe Dean's Award for Liferime
Achievemenr in Teaching ar Weill Medical College of
CorneJi Universiry.
In addirion w his many orher honors, awards and
prizes, Clayson once nored wirh pleasure rhar a former
srudenr had named his nrsr son afrer him. In a recenr
inrerview, Clayson said: "I always rell my srudenrs rhey
are my purpose and my family."

Editor's note: Dr. Clayson had the opportunity to review
and enjoy an earlier version ofthis article a jew days before
his death.
Summer 2001
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Reunion 2001 awardees (left to right): Robert M. Senior, MD; Frank Vellios, MD; Richard W.
Hudgens, MD; Alan L. Pearlman, MD; Theodore C. Feierabend, MD ; Herbert T. Abelson, MD.
EDICAL ALUMNI from

the Classes of'41, '46,
'51, '56, '61 , '66, '71, '76,
'81, '86 and '91 gathered together
over three fun -filled days, May
10-12,2001 , to catch up on one
another's careers and lives, and to
reminisce about the "good oM days"
at the School of Medicine.
Six outstanding alumni/faculty
were given special awards. Enjoy a
taste of the weekend's highlights on
the following pages .

•• • • • •••• • • • • •• •• • • • • •• • • •
Distinguished Service Award

Robert M. Senior, MD, is Dorothy R. and
Hubert C. Moog Professor of Pulmonary
Diseases in Medicine and professor of cell
biology and physiology at the School of
Medicine. He is highly respected as a
clinician and teacher and has played an
important role in the life of the medical
school and its affiliated hospitals. Senior
is currently principal investigator of two
studies funded by the National Heart,
Lung and Blood Institute.
Outlook Summer 200 I

Alumni Achievement Awards

Alumni/Faculty Awards

Herbert T. Abelson, MD'66, is the George
M. Eisenberg Professor and chairman of
pediatrics at the University of Chicago
Pritzker School of Medicine and physician
in-chief at University of Chicago Children's
Hospital. He has served on several distin
guished journals and, in 1997, as the chair
man of the American Board of Pediatrics.
Theodore C. Feierabend, MD '51, is
a retired medical missionary now living in
Madison WI. He is a member of the board
of the ecumenical Triangle Community
Ministry, which serves an area of public
housing and private low-income housing in
the city. He has trained physicians in India
and Afghanistan, and opened a department
of plastic and reconstructive surgery and a
bum unit in northern India.
Frank Vellios, MD '46, is retired
but continues to serve as a consultant in
surgical pathology at St. Joseph's Hospital
in Atlanta. He hetd faculty positions at a
number of medical schools and served as
editor-in-chief of the American Journal
of Clinical Pathology.

Richard W. Hudgens, MD '56, is profes
sor of psychiatry at the School of Medicine
and has served the department in a variety
of capacities. He was the first faculty
member named Teacher of the Year, an
award created by the Class of 1966, and
was among those named Clinical Teacher
of the Year by the Class of 2001. He has
regularly served as reunion chairman for
his class.
Alan l. Pearlman, MD '61, is profes
sor of neurology and of cell biology and
physiology at the School of Medicine and
is also director of the neurology service
at St. Louis ConnectCare. He is the
coursemaster for the second-year course,
Diseases of the Nervous System, and
directs the third-year neurology clerkship.
Students have repeatedly honored his
teaching by bestowing upon him the
Distinguished Service Teaching Award,
Clinical Teacher of the Year, and Professor
of the Year. He regularly serves as his
class reunion chairman.
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Michael Lewis, M0 '76, and class social
chair John Milton, M0 '76, are all
smiles at the welcoming reception.

TnHJRVW<G-nH
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Dancing the night away, Arthur Schmidt, MD '46,
and his wife, Joane.

Dick Hawkins, MD '46, and James Sisk, MD '46,
catch up at the reunion banquet.

Members of the Class of 1961, from left, Benje
Boonshaft, MO; Arthur Clements, MD ; Morton Levy, MD;
Phil Woerner, MD, and David Reisler, MD.

Richard Hudgens, MD '56, and Stanley Smith, MD '56,
visit at the welcoming reception ,
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From left, Walter German, MO '51 ; Lowell Gess, MO '51 ,
and Taney German, NU '50.
Sum mtT 200 I
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Joe Moreland, MD, and Cramer Reed, MD,
both from the Class of 1941, reminisce at
their class dinner.

Marvin Levin, M0, welcomes
his classmates to the
class dinner.

~ltEMl£Ml5l£~
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Oren Conway, M0 '71 , and. his wife, Rose,
attend the "Docs Off Duty" program.

From left, Penny George; Philip George, M0 '66;
class social chair Kevin Schaberg, MD '66;
Tosca Schaberg; Erin Crane; Fay Bisno, and
David Bisno, M0 '66.
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"Docs Off Duty" participant
Alison Stuebe, M0 '01 , explains
how she designed on-line study
guides that are now used at
the School of Medicine.

Class of 2001 president Andy Josephson,
M0, speaks at the reunion banquet.
Outlook Summ er 200 I
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Robert Anschuetz, MD '76, shares
a memory at the Class of 1976 dinner.
Members from the Class of 1961,
from left, John Balfour, MD;
Ron Rosenthal, MD, and John Crosson, MD.

$1HLm!]eJ[~«E~
1{8lA[~
Capturing memories of
his 50th Reunion, George
Krietmeyer, MD '51, takes
a photo at his class dinner.

From left, Herb Iknayan, MD '56; Shelia Iknayan; Toni Johnson,
and Alan Johnson, MD'56, at the welcoming reception.

Jill Trice, MD '76, speaks at
the scientific presentation
about lupus and her personal
battle with the disease.

J. William Campbell, MD '77, incoming president of WUMCAA,
accepts the gavel from outgoing president, Thomas Pohlman, MD'76.

Betty Knoblock, NUl '51, and Frank Vellios, MD '46,
enjoy a story told at the Class of 1946 dinner.
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Samuel Schechter, MO '41; Norma Bonham, and
class social chair Vergil Slee, MO '41, at the
Khorassan Room.

"

l

From left Marlene Jessurun ; Eric Vaughn, M0 '91 ; Shona Clay,
and Carlos Jessurun, MO '91 , visit with William A. Peck, MO,
dean of the School of Medicine.

Pankaj Gore, Ann Tilley, Paula Gerber
and' Chris Combs from the Class of
2001 celebrate at the reunion banquet.

/

Charles Goldman, M0 '81 , Tom Prater, M0 '83, Micki
Klearman, MO '81 , and Janice Semenkovich, MO '81,
enjoy hearing from other classmates.

I~

Peggy Gramates, M0 '91, Pearl Serota,
MO '91, and' Harvey Serota, MO & FHS '88,
at the Class of 1991 dinner.
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Reunion is a family affair for
Mandy Ooumit; Aziz Ooumit,
MO '91, and their son,
Samser "Sam:'
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Class Notes
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40S

EImer B. Miller, MD '43, a

rerired general surgeon,
wrires rhar he is "living
wirh my wife, judy, and our 16-year-old
son in rhe middle of a traer of Carolina
foresr, where I rend five dogs, five cars,
a goar, a donkey, ducks, geese, er al."
The Millers live at Pirrsboro NC.
Russell D. Shelden, MD '49, is
president of rh e Mi ssouri Senior Golf
Associarion. He lives in Kansas City.

50S

Dottie Llewellyn Rodgers,
MD '50, has sold her

property in Columbia
MO, and become a Californian. She is

enjoying being able to garden year-round.
Her granddaughrer, Sarah Schooler,
graduared from medical school ar rhe
Un iversity of Virginia in May.
Godofredo Herzog, MD '57, reti red
from pracrice in Seprember 2000 and
now lives in Longboat Key FL, where
he enjoys beaches, biking and rravel.
He wrires rhar he is "srill married
to Eva, and loving ir for the past 44
years. " The Herzogs have three married
children and seven grandchil dren
who visir frequentl y. His next project
is to wrire a memoir and perhaps
a novel.

60S

Margaret l. Hayes, MD,
HS '66, is retired but

i
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keeps involved wirh
hospiral and medical society affairs in
Dayton OH. She chairs the Erhics
Comminee of rhe Monrgomety County
Medical Society. She says, "I do miss
delivering babies, bur I don't mi ss
insurance companies, erc. I've done
some traveling and learned to play
bridge. Golf may be next! "
James McCulley, MD '68, chairman

of ophthalmology at rhe University of
Texas Sourhwestern Medical Center,
has been named to the board of direc
tors of Readi ng and Radio Resource, a
Dallas organization devoted to meet
ing the reading needs of peop le who
are visually, physically and learning
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impaired. McCulley direcrs rhe Jean
H. & John T. Walter jr. Center for
Research in Age- Relared Macular
Degenerarion and holds the David
Bruton] r. Chair in Ophrhalmology.

~OS

laura Wexler, MD '71, has

been appointed associ
are dean of student
affairs and admissions at rhe University
of Cincinnati College of Medicine,
where she has been since 1987 . She
was form erly chief of cardiology ar irs
affiliared Veterans Affairs Medical
Cenrer and interim chief of the division
of cardiology at rhe University of
Cincinnari Medical Center.
Charles R. Noble, MD, HS '74, retired
from his solo privare practice of der
matology on August 31, 2000. He
lives in Orlando FL.

Roger Alan Brumback, MD, HS '75,
on January 1, 200 1, becam e professor
and chairman of the deparrmenr of
pathology ar Creighton Universiry
School of Medicine and St. joseph
Hospiral in Omaha NE.
AI Brock King, HA '76, is president of
Memphis Managed Care Corporation .
Sanford P. Sher, MD '76, of
Philadelphia has been busy obtaining a
state historic marker for Mowe r
Gen eral Hospital , which was recently
dedicared. Mower, one of the largesr
and most innovative hospitals during
the Civil War, had 3,600 beds and
rreated more than 20,000 parients
from every major battle from
Gettysburg until the end of the war.
Scott Greenwood, !VI D '77, and Pam
Freeman, MD '77, live in Orlando FL,
where he is president of rhe Orlando
Heart Center and managing partner
of a 16-member group, and she prac
tices wi rh Caryn Hasselbring, MD '82.
Pam recently was chosen as "Best
Rheumatologisr in Central Florida" by

Orlando Magazine.

Charles EHelson, Mil '78, is serving
rhis year as president of the medical
staff at Sr. Luke's Hospital in

Chesterfield MO. He is also chief
of rhe Section of Plastic Surgery at
St. Luke's, where he has been in priva te
practice since 198 3.

Scott A. Mirowitz, MD '85,

80S

began a new posirion
March 1,2001, as pro
fessor and chairma n of [he depanmel1t

of radiology at the University of
Pirrsburgh Medical Center.

Clifford V. Harding III, MD, PhD '85,
has been named director of rh e
M edical Scienri sr Training Program at
Case Western Reserve University
School of Medicine in Cleveland. A
pro fessor of pathology and oncology
there, Harding has been on th e faculty
since 1993. Hi s research interests are
in immunology and cell biology, and
relate to clinical problems in infectious
diseases.

90S

Sharon Meyer Schwartz,
OT '95, and husband

Sreve celebrared daughter
Alyssa's Ba[ Mitzvah in March. Their

son, Michael, is a varsi ty soccer and tennis
player in high school and an aspiring
cardiologist. They live in Plainview NY.
NichollVl. Trump lee, MD '95, and
husband Gabriel are two of three
pediatrician s at the Naval Hospital at
Naval Air Station in Lemoore CA.
They enjoy a busy outparienr practice ,
with occasio nal inpa[i enrs and about
30 deliveries a month. They have
"ample opportunity to participare in
th e administrative side of milira ry
medicine as well." The Lees plan to
be there another twO years or so and
would love to hear from c1assma[es
rraveling rheir way.

Charles K. lee, MD '97, writes
thar he married "the love of my life, "
Nakyung Kim, MD , on June 18,
2000 , in Chicago, where they live . He
recentl y finished his portion of general
surgery and began his plastic surge ry
fellowship at the University of Chicago.
The couple honeymooned in Portugal ,
Korea and Thailand.
Summer 200 1 Outlook

Carrie Dickinson Salyer, DT '97,
married Rob Salyer on September 16,
2000, at Graham Chapel on the
Washington University campus. She
is employed by the Hazelwood School
District Early Childhood Program as
an occupational therapist. The Salyers
live in St. Peters MO.
Jennifer Meko, MD, HS '98, is finish
ing the last six months of a two-year
cardiothoracic fellowship at MemoriaJ
Sloan-Kettering Cancer Center and
New York Hospital/Cornell in New
York City and is looking for a position
as a general thoracic surgeon. She
writes, "My husband stays home with
the kids and keeps our lives organized.
We have had a blast living in New
York City, but we currently have an
acute shortage of space in our apart
ment, so it's time to move on l "

IN MEMORY
lloyd Penn, MD '33, died on December 29,
2000, in San Francisco at the age of
93. A physician and surgeon, he was
a charter, life member and Fellow of
the American Academy of Family
Physicians. He had been on the staff
of St. Francis Memorial Hospital since
1934. During World War II, he served
as a commander in the U.S. Navy
Medical Corps. He was active in
Masonic Lodges, both York and
Scottish Ri te bodies, for more than
50 years. An enthusiastic fresh and salt
water fisherman, he had fished in the
United States, Mexico, Canada, Egypt,
New Zealand and China. He was the
husband of the late Goldie Penn, after
whose death he married Jean Penn,
who survives. Other survivors include
a son, William Lyttleton Penn, and
three sisters.

Gladys Johnson Askey Ezell, NU '40,
died of pneumonia on December 25,
2000, in Seguin TX at the age of 84.
During World War II she served in the
Washington University hospital unit
in Africa, Italy and France and later
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did postgraduate work at Columbia
University in New York. She was
a nurse and nursing supervisor at
Veterans Administration hospitals and
clinics for 27 years. She was the widow
of Fred Askey and the wife of Howard
Ezell, whom she married in 1982.
In addition to her husband, she is
survived by a son.
Henry H. Caraco, M[I '41, died in
California on March 7, 200 I.

Ernestine Boylan Shugart, NU '46,
died in Texas on March 25,2001.
Joe R. Utley, M0 '60, died in
Spartanburg Sc, on January 15,2001,
following a long illness. He was 65. A
cardiothoracic surgeon, he practiced in
California and Kentucky prior to
moving to South Carolina in 1983,
where he was chief of cardiac surgery
at Spartanburg Regional Medical
Center until his retirement in 1995.
In the early '60s he served as a Right
surgeon in the U.S. Air Force. He
founded the Cardiothoracic Research
and Education Foundation for fur
thering knowledge related to cardio
pulmonary bypass surgery in 1979.
An enthusiastic musician, he played
trumpet with the Spartanburg
Symphony Orchestra and, with his
wife, amassed a collection of rare
brass instruments that resides at
America's Shrine to Music Museum
in Vermillion SO, where the Utleys
established the Joe R. and Joella F.
Utley Insti tu te for Brass Studies.
His wife of 44 years, Joella F. Utley,
MD '67, a radiation oncologist, survives,
along with a son, a daughter and
other rei a tives.
Mary Kay Burgess, DT '69, of St. Louis
MO, died of cancer on March 13,2000.
She was 53.

FACULTY
Viktor Hamburger, PhD, famed biologist
and the Edward Mallinckrodt
Distinguished Universi ty Professor
Emeritus in Arts & Sciences, died

Tuesday, June 12, 200 I, in St. Louis
after a short illness. He was 100.
Hamburger was considered a gia!1( in
neurobiology, embryology and the
study of programmed cell death, and
often has been referred to as "the
father of neuroembryology." He
earned a doctorate from the University
of Freiburg in 1925. After completing
postdoctoral studies in Germany, he
received a Rockefeller Fellowship to
study for a year with Frank Lillie at
the University of Chicago in 1932.
His intended one-year stay in the
United States became extended indefi
nitely when he received word that he
was not welcome to return to Freiburg
due to Hitler's "cleansing" of German
universities. Hamburger joined the
Washington University faculty in 1935
as assistant professor of zoology.
Within six years he had advanced to
full professor and department chair.
He continued to serve as chair until
1966 and was appointed the Edward
Mallinckrodt Distinguished University
Professor of biology in 1968. He
assumed emeritus status in 1969 but
maintained an active, well-funded
research program until he was well
into his 80s.
Hamburger received many honors
and accolades, including the National
Medal of Science, the Horwitz Prize,
the Harrison Award, the Gerard Prize
and, most recently, the inaugural
Lifetime Achievement Award from the
Society for Developmental Biology,
conferred June 7, 2000. He also was a
member of the National Academy of
Sciences and the American Academy
of Arts and Sciences. Hamburger was
preceded in death by his wife, Martha
Fricke Hamburger, in 1965. He is sur
vived by daugh ters Carola Marte,
MD, a physician in New Haven CT,
and Doris Sloan, PhD, professor
emerita of geology at the University of
California, Berkeley, and by four
grandchildren, twO great-grandchil
dren and a great-great-grandson.
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Here's how it works ...

Sample Rates of Return

If both you and your spouse are .. ...... ...... age 55
And create a Deferred-Payment
Gift Annuity with ........... .... ... ........ ...... $10,000
Which will begin paying income to
both of you at ..... .. ....... .. .. .. .. .. .......... .. age 65
The two of you will receive annual

Which is a return of .............. .. ................ 10.9%

k.

Your immediate charitable

Ultimately, the amount remaining from your gift
Washington University.
* Amount of the charitable deduction may vary slightly.

Age Payments Begin

45

65

20.3%

50

65

15.3%

55

65

11.6%

60

65

8.8%

Rates of Return

Age
45 & 45

Age Payments Begin
65

Rates of Return
19.1%
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65

deduction is ................. .... ... ..............$4,183*

will be used for a purpose you choose at

Age

Double Life

lifetime income of ........... .. ................. $1,090

of the amount you transferred .

Single Life

60 & 60

65

8.3%

Individuals over age 65 may find an immediate
Charitable Gift Annuity or a Charitable Remainder
Unitrust more attractive .

~ Washington

University in St.louis

D Please send me your booklet on Deferred-Payment
Charitable Gift Annuities .

SCHOOL OF MEDICINE
D Washington University is already included in my estate
plans--I would like to become a Robert S. Brookings
"Partner. "
D Please send me a personalized. confidential calculation
using the following birthdate(s) to illustrate the very
amactive benefits that I will receive from a Washin gton
Un iversity Deferred-Payment Charitable Gift Annuity.
I prefer to have my payments begin (minimum age 60):
D Immediately

D When I reach age _ __

D I wou ld like a calculation based on a theoretical gift: of:
$

.

D Please send me your booklet on other Life Income
Plans at Washington University.
D Please send me information on making a bequest to
Washington University School of Medicine.
D Please have Paul Schoon or Lynnette Sodha from the
Washington University Planned Giving Offi ce call me.
Name ______________________________________
Address _ _ _ __ _ _ _ _ _ _ _ _ __ _
City/State/~ip

Daytime Phone _____ __ _ _ _ _ _ _ __

(minimum $5,000)
II.

D Cash

D Securities

$ -....,.-:--~
(COSt Basis)

(Acquisitio n Date)

First Beneficiary
Birthdate

Relationship______________

Second Beneficiary
Birthdate

Relationship____________

~ Washington

University in St.louis

SCHOOL OF MEDICINE
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(Fold this form and sea l edges with tape to mail. )

Use this postage-paid card to let us know what's new with you.
Share your news about awards and honors, promotions, community activities
and more, Contact Chad Ittner at (314) 286-0020 or e-mail Ruth Bebermeyer
at ruthab@onemain,com,

Update Yourself!
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The University reserves the right to
contact contrib utors to verify entries.
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Alzheimer's on Stage Members of the
St. louis Black Repertory Company perfonn "The Eighth
Day of the Week,· a play about African-American family
members' struggle to care for their mother, who has
memory loss and dementia. Sponsored by the School of
Medicine and ils Alzheimer's Disease Research Center,
the Alzheimer's Association of St. louis, and the Black
Rep. the production aimed to increase awareness of
the disease in the African-American community and to
educate the public about lis early warning signs.
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